02 Apr neurodAIgnostics appoints Arnaud Bistoquet, PhD, as Co-Founder and Chief Executive Officer
neurodAIgnostics today announced the appointment of Arnaud Bistoquet, PhD, as Co-Founder and Chief Executive Officer. In this role, Arnaud will lead the company’s strategic vision and operational growth as it accelerates the development of next-generation cognitive assessment technologies.
Arnaud brings a unique combination of scientific expertise and strategic business development experience to neurodAIgnostics’ mission of transforming how cognitive functions are assessed and monitored. He earned his PhD from the Georgia Institute of Technology, where his research focused on machine learning applications in medical imaging. Over the past decade, he has built extensive experience at the intersection of healthcare, data, and strategy. His career spans strategy consulting in the pharmaceutical industry, as well as roles in digital health startups and MedTech organizations, where he contributed to the development and scaling of innovative healthcare solutions.
As CEO and Co-Founder, Arnaud will guide neurodAIgnostics as it expands its capabilities in AI-powered cognitive assessment. “I am excited to join neurodAIgnostics at such an important stage,” said Arnaud. “The convergence of AI, clinical insight, and real-world data offers tremendous potential to transform cognitive assessment. I look forward to working with the team to build solutions that advance research, support clinicians, and improve the lives of patients.”